Fingerprint
Dive into the research topics of 'Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer
Howard Hochster, Erika Kettner, Hendrik Kröning, Klaus Becker, Florian Lordick, Ramesh K. Ramanathan, John Macdonald, Shengyan Hong, William John, Hans Joachim Schmoll
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations